Does LERCANIDIPINE Cause Dermatitis exfoliative generalised? 25 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Dermatitis exfoliative generalised have been filed in association with LERCANIDIPINE. This represents 0.7% of all adverse event reports for LERCANIDIPINE.
25
Reports of Dermatitis exfoliative generalised with LERCANIDIPINE
0.7%
of all LERCANIDIPINE reports
3
Deaths
11
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From LERCANIDIPINE?
Of the 25 reports, 3 (12.0%) resulted in death, 11 (44.0%) required hospitalization.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Hyperkalaemia (176)
Drug ineffective (149)
Diarrhoea (122)
Hyponatraemia (122)
Renal impairment (120)
Oedema peripheral (114)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which LERCANIDIPINE Alternatives Have Lower Dermatitis exfoliative generalised Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN